Molecular characterization of biliverdin IXbeta reductase

胆绿素 IXbeta 还原酶的分子表征

基本信息

  • 批准号:
    10210076
  • 负责人:
  • 金额:
    $ 49.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-07-01 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

Name of Applicant (Last, First, Middle): BAHOU, Wadie F. Project Summary/Abstract Research proposed in this grant application builds on extensive genetic, biochemical and animal studies designed to further characterize and validate biliverdin IX reductase (BLVRB) as a novel cellular target regulating human platelet production in situations of stress hematopoiesis, with concomitant effects on erythroid development and repopulation. Although heme degradation is largely studied as a processing pathway designed to clear pro-oxidant (free) heme generated during cellular senescence (or metabolism), heme catabolic enzymes are also known to maintain function(s) in cellular signaling and cytoprotection, and tetrapyrrole byproducts biliverdin (BV) and bilirubin (BR) function in redox reactions as potent buffer(s) against oxidant stress. We now challenge existing dogma, hypothesizing that redox-regulated activity involving heme catabolism functions in a unique metabolic pathway controlling hematopoietic lineage fate with divergent effects on erythroid/megakaryocyte balance. Research goals are accomplished through two synergistic specific aims, designed to (1) delineate cellular mechanisms of BLVRB-regulated Mk/Erythroid redox coupling and cytoprotection in vitro, and (2) define and expand upon mechanisms of lineage-restricted speciation and cytoprotection in vivo, collectively designed to dissect Blvrb-regulated perturbed pathways controlling E/Meg lineage speciation from MEPs during stress hematopoiesis. Basic science implications are broadly relevant to (1) metabolic and bioenergetic consequences of hematopoiesis, (2) heme-regulated redox chemistry, and (3) novel cellular target validation. Clinical/translational implications are designed to enhance our understanding of mechanisms of disease pertaining to stem cell metabolism, aging, anemia and platelet production. Unique reagents and cell lines generated and characterized include (1) murine models of Blvrb- and Blvra-deficiency, (2) iPSC models with targeted BLVRB knock-outs, (3) biliverdin IX (and IX, IX) isomer detection and production methodologies. All proposed studies are formulated on pre-existing studies in subject cohorts, and proposed experiments are predicated on reagents and expertise currently available or in advanced development among the research team. PHS 416-9 (Rev. 6/09) Page Continuation Format Page
申请人姓名(最后、第一、中):BAHOU, Wadie F。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wadie F Bahou其他文献

Wadie F Bahou的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wadie F Bahou', 18)}}的其他基金

Molecular characterization of biliverdin IXbeta reductase
胆绿素 IXbeta 还原酶的分子表征
  • 批准号:
    10580034
  • 财政年份:
    2021
  • 资助金额:
    $ 49.3万
  • 项目类别:
Molecular characterization of biliverdin IXbeta reductase
胆绿素 IXbeta 还原酶的分子表征
  • 批准号:
    10442710
  • 财政年份:
    2021
  • 资助金额:
    $ 49.3万
  • 项目类别:
Platelet Systems Biology in Health and Disease
健康和疾病中的血小板系统生物学
  • 批准号:
    8791400
  • 财政年份:
    2015
  • 资助金额:
    $ 49.3万
  • 项目类别:
Genetic dissection of the platelet thrombohemorrhagic phenotype
血小板血栓出血表型的基因剖析
  • 批准号:
    8287112
  • 财政年份:
    2009
  • 资助金额:
    $ 49.3万
  • 项目类别:
Genetic dissection of the platelet thrombohemorrhagic phenotype
血小板血栓出血表型的基因剖析
  • 批准号:
    7749777
  • 财政年份:
    2009
  • 资助金额:
    $ 49.3万
  • 项目类别:
Genetic dissection of the platelet thrombohemorrhagic phenotype
血小板血栓出血表型的基因剖析
  • 批准号:
    8069931
  • 财政年份:
    2009
  • 资助金额:
    $ 49.3万
  • 项目类别:
Genetic dissection of the platelet thrombohemorrhagic phenotype
血小板血栓出血表型的基因剖析
  • 批准号:
    7903300
  • 财政年份:
    2009
  • 资助金额:
    $ 49.3万
  • 项目类别:
MOLECULAR BASIS OF ESSENTIAL THROMBOCYTOSIS
原发性血小板增多症的分子基础
  • 批准号:
    7950798
  • 财政年份:
    2008
  • 资助金额:
    $ 49.3万
  • 项目类别:
EFFECT OF ASPIRIN ON PLATELET AND MEGAKARYOCYTE GENE PROFILES
阿司匹林对血小板和巨核细胞基因谱的影响
  • 批准号:
    7950825
  • 财政年份:
    2008
  • 资助金额:
    $ 49.3万
  • 项目类别:
MOLECULAR BASIS OF ESSENTIAL THROMBOCYTOSIS
原发性血小板增多症的分子基础
  • 批准号:
    7607893
  • 财政年份:
    2007
  • 资助金额:
    $ 49.3万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 49.3万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.3万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 49.3万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.3万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 49.3万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 49.3万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.3万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 49.3万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 49.3万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 49.3万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了